Key facts
- This page summarizes John J. Sperzel III's Form 4 filing for T2 Biosystems, Inc. (TTOO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Feb 2022, 15:00.
John J. Sperzel III - 24 Feb 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)
- Reporting relationship
- Chairman, Chief Executive Officer and President, Director
- Issuer ticker
- TTOO
- Reported as of
- 24 Feb 2022
- Net transaction value
- -$63,532
- SEC form
- 4
- Accepted by SEC
- 28 Feb 2022, 15:00:17 UTC
- Prior SEC filing
- 23 Feb 2022
- Next SEC filing
- 11 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Gibbs, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John J. Sperzel III filed Form 4 for T2 Biosystems, Inc. (TTOO) on 28 Feb 2022.
Change
- Previous filing in this sequence was filed on 23 Feb 2022.
- Current net transaction value: -$63,532.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TTOO
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +333,333
- Change %
- Price
- Shares after
- 333,333
- Date
- 24 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
TTOO
transaction
Common Stock
Tax liability
- Transaction value
- $63,532
- Shares
- -141,560
- Change %
- -42%
- Price
- $0.4488
- Shares after
- 191,773
- Date
- 24 Feb 2022
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TTOO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -333,333
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 666,667
- Date
- 24 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 333,333
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
141,560 shares of common stock were automatically withheld at vesting to cover required tax withholding.
Footnote F3
On February 24, 2021 the reporting person was granted 1,000,000 RSU's that vest in three equal installments commencing on February 24, 2022.
SEC remarks
Chairman, Chief Executive Officer and President